Milan, Italy, 28 February 2025 – The Global Credit platform of Carlyle (NASDAQ: CG) and Arcmont Asset Management, a leading European private credit asset management firm, today announced that they have arranged – together with Natixis – a €470 million financing package for Bianalisi, a leading independent platform for integrated healthcare diagnostics in Italy. The transaction will enable Bianalisi to continue supporting the ongoing expansion of its platform by investing in the consolidation of the Italian healthcare diagnostics market as well as to refinance existing debt.
With a widespread presence in 13 Italian regions, Bianalisi offers a full range of services in clinical laboratory diagnostics, outpatient care and diagnostic imaging through a network of 350 labs and sample collection points, more than 70 outpatient care facilities, and 46 diagnostic imaging centers. Bianalisi has enjoyed significant growth over its 30-year history, both organic and through M&A, thanks to the efforts of its experienced management team, who today is led by CEO Giovanni Gianolli. Since receiving investment from Charme Capital Partners – an Italian private equity firm investing in Italy, UK and Spain – in 2021, Bianalisi has enjoyed an acceleration of its growth journey, with over 60 acquisitions completed since then.
Giovanni Gianolli, CEO of Bianalisi, said: “Thanks to this transaction, Bianalisi has secured substantial financial resources to continue its growth journey. We are delighted to partner with global investors such as Carlyle, Arcmont and Natixis who have chosen to support the continued consolidation project of Bianalisi in a highly promising sector. Their expertise and capital will help us further capitalize on the fragmented Italian healthcare market as we look to grow upon our strong market position.”
Nicola Falcinelli, Deputy Head of European Private Credit at Carlyle, said: “We are pleased to support Bianalisi to further expand its delivery of critical healthcare services to Italian patients and healthcare professionals. The Italian market is one Carlyle knows well and we have been very active providing flexible credit solutions to both sponsor-backed and non-sponsored companies to further their growth.”
Vanni Mario Zanchi, Partner at Arcmont, said: “We are pleased to provide this significant backing for Bianalisi, one of Italy’s leading medical diagnostics businesses. It meets many of the criteria we look for in an investment, including financial strength and stability and significant scope for continued growth. We look forward to working closely with Giovanni and his team in achieving their business goals while serving the needs of thousands of patients every day.”
About Bianalisi
Bianalisi is a leading independent integrated diagnostics platform in Italy, offering healthcare services in laboratory diagnostics, outpatient diagnostics, and imaging diagnostics. With a widespread presence across 13 Italian regions, Bianalisi serves over 15,000 patients daily. Each year, the Group performs more than 1.5 million outpatient and imaging diagnostic visits and conducts approximately 20 million clinical tests, thanks to the work of over 1,500 doctors and 1,000 employees.
About Carlyle
Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Global Investment Solutions. With $441 billion of assets under management as of December 31, 2024, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents.
Carlyle’s Global Credit platform manages $192 billion in assets under management, as of December 31, 2024. It regularly pursues investments in privately negotiated capital solutions partnering with high-quality sponsors and leading family or entrepreneur-owned companies.
Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.
About Arcmont
Arcmont Asset Management, an investment affiliate of Nuveen, the investment manager of TIAA, is a private debt asset management firm providing flexible capital solutions to a wide range of businesses in Europe. Established in 2011, Arcmont has raised approximately €31 ($33) billion in assets to date from institutional investors globally and has committed over €31 ($33) billion across more than 410 transactions. With a highly experienced investment team, a strong investment track record and deep technical expertise, Arcmont offers creative and flexible capital solutions to European businesses, with the reliability of a partner that values long-term relationships. Headquartered in London, Arcmont’s presence spans Amsterdam, Frankfurt, Madrid, Milan, Munich, Paris, Stockholm and New York. it maintains a local origination network and builds and preserves close relationships with sponsors, borrowers and local intermediaries. To learn more about Arcmont, visit www.arcmont.com.
Media Contacts
Bianalisi
Francesca Alibrandi (Value Relations)
+39 335 8368826
Antonella Martucci (Value Relations)
+39 340 6775463
Carlyle
Andrew Kenny
+44 7816 176120
Marina Riva
Barabino
+39 347 2975426
Arcmont
Prosek
pro-arcmont@prosek.com
